Safety and Efficacy Evaluations of Topical Microbicide/Biomedical Prevention Products in the Repeat Low-Dose Macaque SlV /SHIV Infection Model

Abstract

The purpose of this agreement is to develop safe and effective biomedical interventions to reduce transmission of human immunodeficiency virus (HIV) and the burden of acquired immunodeficiency syndrome (AIDS) disease.

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: NIH Inter-Agency Agreements (Y01)
Project #: AAI12041001-1-0-1
Application #: 9359097
Study Section

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year: 2016
Total Cost
Indirect Cost

Institution

Name: National Institute of Allergy and Infectious Diseases
Department
Type
DUNS #

City
State
Country
Zip Code

Related projects


NIH 2016 Y01 AI	Safety and Efficacy Evaluations of Topical Microbicide/Biomedical Prevention Products in the Repeat Low-Dose Macaque SlV /SHIV Infection Model / National Institute of Allergy and Infectious Diseases
NIH 2015 Y01 AI	Safety and Efficacy Evaluations of Topical Microbicide/Biomedical Prevention Products in the Repeat Low-Dose Macaque SlV /SHIV Infection Model / National Institute of Allergy and Infectious Diseases

Comments

Be the first to comment on this grant